JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Biochemical Reagent
Signaling pathways

Signaling pathways

BA6613 PD0176078

Summary: A newly discovered N-type calcium channel blocker.
BA6614 Darodipine

Summary: Effective calcium channel antagonist.
BA6616 SRI-41315

≥10.08 mg/mL
BA6617 Vanzacaftor

Summary: Vanzacaftor (VX-121) is a new orally effective corrective agent.
BA6618 NJH-2-057

Summary: A deubiquitinase covalent ligand-linked lumacaftor conjugate that stabilizes mutant proteins in cells.
BA6619 Bamocaftor

Summary: Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance modulator corrector designed to restore protein function.
BA6620 Navocaftor

Summary: Navocaftor (GLPG3067) as a cystic fibrosis transmembrane modulator.
BA6621 Cavosonstat

Summary: Cavosonstat (N91115) is an orally active inhibitor.
BA6622 Galicaftor

Summary: An effective, orally active transmembrane conductance modulator corrector for cystic fibrosis
BA6623 SRI-37240

Summary: SRI-37240 is a potent early termination codon inhibitor.

≥10.06 mg/mL